<DOC>
	<DOCNO>NCT00728650</DOCNO>
	<brief_summary>This study review treatment outcomes patient primary metastatic hepatic malignancy . Patients treat surgical resection , percutaneous radiofrequency ablation ( RFA ) , transarterial chemoembolization ( TACE ) compare patient receive treatment . Tumor recurrence survival data compare published literature determine efficacy current treatment strategy patient population .</brief_summary>
	<brief_title>A Retrospective Review Malignant Liver Tumors</brief_title>
	<detailed_description>Subjects identify diagnosis procedure cod university surgical practice St. John Medical Center Cancer Registry . Data obtain review clinic hospital chart . In addition plan review utilize liver tumor treatment outcomes data national database . Treatment decision , case manage primary investigator , make clinical basis , often collaboration interventional radiologist . Of patient manage principal investigator , procedures undertaken informed consent process . Subjects expose risk beyond pose recommended treatment . All treatment within scope standard medical care . The primary investigator knowledge treatment choose patient manage . The subject 's refer physician may contact obtain follow-up data subject . The follow-up data include : patient alive disease ; alive without disease , alive unknown ; dead free disease ; dead disease ; dead unknown .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Patients primary metastatic hepatic malignancy Patients diagnose primary metastatic hepatic malignancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>colorectal carcinoma metastatic liver</keyword>
	<keyword>primary liver cancer</keyword>
</DOC>